Edgestream Partners L.P. purchased a new position in Globe Life Inc. (NYSE:GL – Free Report) during the first quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 53,984 shares of the company’s stock, valued at approximately $7,513,000.
Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Bull Harbor Capital LLC purchased a new stake in Globe Life during the 1st quarter valued at approximately $538,000. Amundi lifted its holdings in shares of Globe Life by 627.5% in the first quarter. Amundi now owns 39,821 shares of the company’s stock worth $5,542,000 after buying an additional 34,347 shares in the last quarter. EverSource Wealth Advisors LLC lifted its holdings in shares of Globe Life by 4.0% in the first quarter. EverSource Wealth Advisors LLC now owns 2,366 shares of the company’s stock worth $329,000 after buying an additional 91 shares in the last quarter. California State Teachers Retirement System boosted its position in shares of Globe Life by 18.0% during the first quarter. California State Teachers Retirement System now owns 90,478 shares of the company’s stock worth $12,592,000 after acquiring an additional 13,806 shares during the last quarter. Finally, Royal Bank of Canada boosted its position in shares of Globe Life by 3.8% during the first quarter. Royal Bank of Canada now owns 185,786 shares of the company’s stock worth $25,855,000 after acquiring an additional 6,774 shares during the last quarter. 81.61% of the stock is currently owned by institutional investors.
Globe Life Price Performance
Shares of Globe Life stock opened at $179.69 on Thursday. The stock has a market cap of $13.95 billion, a price-to-earnings ratio of 11.93 and a beta of 0.47. The company has a debt-to-equity ratio of 0.38, a quick ratio of 0.07 and a current ratio of 0.07. The stock has a 50 day moving average price of $170.49 and a 200-day moving average price of $153.78. Globe Life Inc. has a one year low of $127.85 and a one year high of $191.55.
Analyst Upgrades and Downgrades
GL has been the subject of several research analyst reports. Wells Fargo & Company raised their target price on shares of Globe Life from $172.00 to $193.00 and gave the company an “overweight” rating in a research note on Thursday, July 9th. Morgan Stanley boosted their price target on shares of Globe Life from $181.00 to $208.00 and gave the stock an “overweight” rating in a research note on Monday, July 6th. Truist Financial increased their price objective on shares of Globe Life from $180.00 to $185.00 and gave the company a “buy” rating in a report on Friday, April 24th. JPMorgan Chase & Co. raised their price objective on Globe Life from $181.00 to $201.00 and gave the company an “overweight” rating in a research report on Tuesday, July 21st. Finally, Jefferies Financial Group lifted their target price on Globe Life from $147.00 to $166.00 and gave the stock a “hold” rating in a report on Friday, July 10th. One investment analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and two have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $191.67.
Check Out Our Latest Report on GL
Insider Buying and Selling at Globe Life
In other news, CFO Thomas Peter Kalmbach sold 25,650 shares of the firm’s stock in a transaction dated Tuesday, July 28th. The shares were sold at an average price of $178.58, for a total value of $4,580,577.00. Following the completion of the sale, the chief financial officer owned 50,568 shares in the company, valued at approximately $9,030,433.44. This trade represents a 33.65% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Frank M. Svoboda sold 20,000 shares of Globe Life stock in a transaction dated Friday, May 22nd. The stock was sold at an average price of $156.68, for a total transaction of $3,133,600.00. Following the transaction, the chief executive officer directly owned 54,020 shares of the company’s stock, valued at approximately $8,463,853.60. This represents a 27.02% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 111,174 shares of company stock worth $18,162,909 over the last quarter. Insiders own 2.11% of the company’s stock.
Globe Life Profile
Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.
The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.
Read More
- Five stocks we like better than Globe Life
- Why SK hynix Could Be the Best AI Chip Stock to Buy Now
- Seagate Technology Stock Surges as Earnings Beat Silences AI Doubters
- Alphabet Is Down 18% From Its High After a Stellar Quarter—Overdone, or More Downside Ahead?
- Why Bloom Energy May Be the Most Important AI Infrastructure Stock
Want to see what other hedge funds are holding GL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Globe Life Inc. (NYSE:GL – Free Report).
Receive News & Ratings for Globe Life Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Globe Life and related companies with MarketBeat.com's FREE daily email newsletter.
